Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126086111 | 12608611 | 1 | I | 20150731 | 20160725 | 20160729 | 20160729 | EXP | JP-PFIZER INC-2016360980 | PFIZER | 65.00 | YR | F | Y | 141.00000 | KG | 20160729 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126086111 | 12608611 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 1X/DAY | 203214 | 5 | MG | TABLET | QD | ||||||
| 126086111 | 12608611 | 2 | SS | MEDROL | METHYLPREDNISOLONE | 1 | 4 MG, DAILY | U | 11153 | 4 | MG | ||||||||
| 126086111 | 12608611 | 3 | SS | CAPISTEN | KETOPROFEN | 1 | U | 0 | |||||||||||
| 126086111 | 12608611 | 4 | C | AZULFIDINE | SULFASALAZINE | 1 | UNK | 0 | MODIFIED-RELEASE TABLET | ||||||||||
| 126086111 | 12608611 | 5 | C | MEILAX | ETHYL LOFLAZEPATE | 1 | Oral | 0 | TABLET | ||||||||||
| 126086111 | 12608611 | 6 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Oral | 0 | |||||||||||
| 126086111 | 12608611 | 7 | C | EPINASTINE | EPINASTINE | 1 | Oral | 0 | TABLET | ||||||||||
| 126086111 | 12608611 | 8 | C | FERROMIA | FERROUS CITRATE | 1 | Oral | 0 | TABLET | ||||||||||
| 126086111 | 12608611 | 9 | C | LOXOPROFEN | LOXOPROFEN | 1 | Oral | 0 | TABLET | ||||||||||
| 126086111 | 12608611 | 10 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
| 126086111 | 12608611 | 11 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 0 | |||||||||||
| 126086111 | 12608611 | 12 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | Oral | UNK | 0 | ||||||||||
| 126086111 | 12608611 | 13 | C | CEREKINON | TRIMEBUTINE | 1 | Oral | UNK | 0 | ||||||||||
| 126086111 | 12608611 | 14 | C | AMITIZA | LUBIPROSTONE | 1 | Oral | UNK | 0 | ||||||||||
| 126086111 | 12608611 | 15 | C | EVISTA | RALOXIFENE HYDROCHLORIDE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126086111 | 12608611 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126086111 | 12608611 | HO |
| 126086111 | 12608611 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126086111 | 12608611 | Gastric ulcer | |
| 126086111 | 12608611 | Gastric ulcer haemorrhage | |
| 126086111 | 12608611 | Injury | |
| 126086111 | 12608611 | Spinal compression fracture | |
| 126086111 | 12608611 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126086111 | 12608611 | 1 | 20150709 | 0 | ||
| 126086111 | 12608611 | 4 | 20150805 | 0 | ||
| 126086111 | 12608611 | 12 | 20151009 | 0 | ||
| 126086111 | 12608611 | 13 | 20151009 | 0 | ||
| 126086111 | 12608611 | 14 | 20151009 | 0 | ||
| 126086111 | 12608611 | 15 | 20151105 | 0 |